New IVIg shows promise in preventing serious infections for Immune-Deficient patients
NCT ID NCT03961009
First seen May 17, 2026 · Last updated May 21, 2026 · Updated 1 time
Summary
This study tested a new intravenous immunoglobulin (IVIg) product called Kedrion IVIg 10% in 47 people with primary immunodeficiency, a condition where the immune system is weak. The goal was to see if it safely reduces serious bacterial infections. Participants received regular infusions, and researchers tracked infection rates and antibody levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY IMMUNODEFICIENCY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AARA Research Center
Dallas, Texas, 75231, United States
-
Allergy Associates of the Palm Beaches
North Palm Beach, Florida, 33408, United States
-
Allergy Partners of North Texas Research
Dallas, Texas, 75230, United States
-
Allergy and Immunology Associates
Little Silver, New Jersey, 07739, United States
-
Dr. Henry J. Kanarek - Allergy, Asthma & Immunology
Overland Park, Kansas, 66211, United States
-
Midwest Immunology Clinic and Infusion Center
Plymouth, Minnesota, 55446, United States
-
Ohio Clinical Research Associates, Inc.
Mayfield Heights, Ohio, 44124, United States
-
Optimed Research
Columbus, Ohio, 43235, United States
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
-
Toledo Institute of Clinical Research Inc
Toledo, Ohio, 43617, United States
-
University of Buffalo
Buffalo, New York, 14203, United States
Conditions
Explore the condition pages connected to this study.